Izzo Luke T, Reyes Tony, Meesala Srijan, Ireland Abbie S, Yang Steven, Sunil Hari Shankar, Cheng Xiao Chun, Tserentsoodol Nomi, Hawgood Sarah B, Patz Edward F, Witt Benjamin L, Tyson Darren R, O'Donnell Kathryn A, Oliver Trudy G
Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, 27710, USA.
Department of Oncological Sciences, University of Utah, Salt Lake City, UT, 84112, USA.
bioRxiv. 2025 Mar 13:2025.03.10.641898. doi: 10.1101/2025.03.10.641898.
Lung squamous cell carcinoma (LUSC) is basal-like subtype of lung cancer with limited treatment options. While prior studies have identified tumor-propagating cell states in squamous tumors, the broader landscape of intra-tumoral heterogeneity within LUSC remains poorly understood. Here, we employ Sox2-driven mouse models, organoid cultures, and single-cell transcriptomic analyses to uncover previously unrecognized levels of cell fate diversity within LUSC. Specifically, we identify a KRT13 hillock-like population of slower-dividing tumor cells characterized by immunomodulatory gene expression signatures. The tumor hillock-like state is conserved across multiple animal models and is present in the majority of human LUSCs as well as head and neck and esophageal squamous tumors. Our findings shed light on the cellular origins of lung hillock-like states: normal club cells give rise to tumors with luminal hillock-like populations, while basal-like tumor-propagating cells transition into basal hillock-like states, resembling homeostatic cellular responses to lung injury. Mechanistically, we identify KLF4 as a key transcriptional regulator of the hillock-like state, both necessary and sufficient to induce KRT13 expression. Together, these results provide new molecular insights into cell fate plasticity that underlies intra-tumoral heterogeneity in LUSC, offering potential avenues for new therapeutic strategies.
肺鳞状细胞癌(LUSC)是肺癌的一种基底样亚型,治疗选择有限。虽然先前的研究已经在鳞状肿瘤中确定了肿瘤增殖细胞状态,但LUSC内肿瘤内异质性的更广泛情况仍知之甚少。在这里,我们采用Sox2驱动的小鼠模型、类器官培养和单细胞转录组分析,以揭示LUSC内先前未被认识到的细胞命运多样性水平。具体而言,我们确定了一个KRT13小丘样的肿瘤细胞群体,其特征是具有免疫调节基因表达特征,分裂较慢。肿瘤小丘样状态在多个动物模型中是保守的,并且存在于大多数人类LUSC以及头颈部和食管鳞状肿瘤中。我们的研究结果揭示了肺小丘样状态的细胞起源:正常的俱乐部细胞产生具有管腔小丘样群体的肿瘤,而基底样肿瘤增殖细胞转变为基底小丘样状态,类似于对肺损伤的稳态细胞反应。从机制上讲,我们确定KLF4是小丘样状态的关键转录调节因子,对诱导KRT13表达既必要又充分。总之,这些结果为LUSC肿瘤内异质性基础的细胞命运可塑性提供了新的分子见解,为新的治疗策略提供了潜在途径。